Go Pro
Guggenheim

Guggenheim Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Guggenheim. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Guggenheim's equity research team. MarketBeat is not affiliated with or endorsed by Guggenheim.

Average Return
00.00% 12-Month ROI
Total Ratings
1,131 Last 12 Months
Buy Ratings
973 Last 12 Months
Sell Ratings
5 Last 12 Months
Companies Covered
386 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Jersey Mike's stock logo
JMKE
Jersey Mike's
$21.80
-0.3%
9/11/2026Boost Price Target$28.00 ➝ $29.00BuyView details for Guggenheim rating of Jersey Mike’s (NYSE:JMKE) on 9/11/2026
Reformation Inc. stock logo
REF
Reformation
$13.96
+6.2%
9/11/2026Reiterated Rating$20.00BuyView details for Guggenheim rating of Reformation (NYSE:REF) on 9/11/2026
RH stock logo
RH
RH
$135.09
+0.8%
9/11/2026Reiterated Rating$200.00BuyView details for Guggenheim rating of RH (NYSE:RH) on 9/11/2026
Pharvaris N.V. stock logo
PHVS
Pharvaris
$38.45
+2.5%
9/10/2026Boost Price Target$40.00 ➝ $44.00BuyView details for Guggenheim rating of Pharvaris (NASDAQ:PHVS) on 9/10/2026
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$37.80
+0.9%
9/9/2026Boost Price Target$54.00 ➝ $57.00BuyView details for Guggenheim rating of IDEAYA Biosciences (NASDAQ:IDYA) on 9/9/2026
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$41.05
+0.3%
9/9/2026Boost Price Target$42.00 ➝ $46.00BuyView details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 9/9/2026
Oracle Corporation stock logo
ORCL
Oracle
$151.48
-1.0%
9/8/2026Reiterated Rating$400.00BuyView details for Guggenheim rating of Oracle (NYSE:ORCL) on 9/8/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$144.21
-0.3%
9/8/2026Boost Price Target$146.00 ➝ $170.00BuyView details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 9/8/2026
X-Energy, Inc. stock logo
XE
X-Energy
$14.93
-5.7%
9/8/2026Reiterated Rating$57.00BuyView details for Guggenheim rating of X-Energy (NASDAQ:XE) on 9/8/2026
Samsara Inc. stock logo
IOT
Samsara
$38.06
-1.0%
9/4/2026Boost Price Target$45.00 ➝ $51.00BuyView details for Guggenheim rating of Samsara (NYSE:IOT) on 9/4/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$163.87
+0.2%
9/4/2026Reiterated Rating$214.00BuyView details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 9/4/2026
lululemon athletica inc. stock logo
LULU
lululemon athletica
$98.24
+1.4%
9/4/2026Reiterated RatingNeutralView details for Guggenheim rating of lululemon athletica (NASDAQ:LULU) on 9/4/2026
Uber Technologies, Inc. stock logo
UBER
Uber Technologies
$71.59
-1.3%
9/3/2026Reiterated RatingBuyView details for Guggenheim rating of Uber Technologies (NYSE:UBER) on 9/3/2026
Five Below, Inc. stock logo
FIVE
Five Below
$245.63
+1.8%
9/3/2026Boost Price Target$250.00 ➝ $290.00BuyView details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 9/3/2026
Alumis Inc. stock logo
ALMS
Alumis
$9.22
-6.9%
9/3/2026DowngradeBuyNeutralView details for Guggenheim rating of Alumis (NASDAQ:ALMS) on 9/3/2026
Snowflake Inc. stock logo
SNOW
Snowflake
$324.84
-1.5%
9/3/2026Reiterated RatingNeutralView details for Guggenheim rating of Snowflake (NYSE:SNOW) on 9/3/2026
EROC
ERock
$12.70
+7.0%
9/2/2026Lower Price Target$23.00 ➝ $20.00BuyView details for Guggenheim rating of ERock (NYSE:EROC) on 9/2/2026
Sphere Entertainment Co. stock logo
SPHR
Sphere Entertainment
$142.34
+0.3%
9/2/2026Boost Price Target$193.00 ➝ $208.00BuyView details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 9/2/2026
Snap Inc. stock logo
SNAP
Snap
$5.69
+3.0%
9/2/2026Reiterated RatingNeutralView details for Guggenheim rating of Snap (NYSE:SNAP) on 9/2/2026
Palo Alto Networks, Inc. stock logo
PANW
Palo Alto Networks
$328.03
-3.1%
9/2/2026Reiterated RatingNeutralView details for Guggenheim rating of Palo Alto Networks (NASDAQ:PANW) on 9/2/2026
GitLab Inc. stock logo
GTLB
GitLab
$46.92
-0.8%
9/2/2026Reiterated RatingNeutralView details for Guggenheim rating of GitLab (NASDAQ:GTLB) on 9/2/2026
MongoDB, Inc. stock logo
MDB
MongoDB
$362.53
-3.0%
9/2/2026Reiterated Rating$560.00BuyView details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 9/2/2026
BlossomHill Therapeutics, Inc. stock logo
BLSM
BlossomHill Therapeutics
$20.87
-3.0%
9/1/2026Initiated Coverage$30.00BuyView details for Guggenheim rating of BlossomHill Therapeutics (NASDAQ:BLSM) on 9/1/2026
Latigo Biotherapeutics, Inc. stock logo
LTGO
Latigo Biotherapeutics
$22.18
+3.0%
9/1/2026Initiated Coverage$50.00BuyView details for Guggenheim rating of Latigo Biotherapeutics (NASDAQ:LTGO) on 9/1/2026
BlossomHill Therapeutics, Inc. stock logo
BLSM
BlossomHill Therapeutics
$20.87
-3.0%
9/1/2026Initiated Coverage$30.00BuyView details for Guggenheim rating of BlossomHill Therapeutics (NASDAQ:BLSM) on 9/1/2026
Latigo Biotherapeutics, Inc. stock logo
LTGO
Latigo Biotherapeutics
$22.18
+3.0%
9/1/2026Initiated Coverage$50.00BuyView details for Guggenheim rating of Latigo Biotherapeutics (NASDAQ:LTGO) on 9/1/2026
The TJX Companies, Inc. stock logo
TJX
TJX Companies
$126.32
-0.1%
8/31/2026 Set Price Target$152.00View details for Guggenheim rating of TJX Companies (NYSE:TJX) on 8/31/2026
Dollar General Corporation stock logo
DG
Dollar General
$124.69
+1.4%
8/31/2026Reiterated Rating$140.00BuyView details for Guggenheim rating of Dollar General (NYSE:DG) on 8/31/2026
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
$1.90
-2.8%
8/31/2026DowngradeBuyNeutralView details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 8/31/2026
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
$115.39
-1.4%
8/31/2026Boost Price Target$135.00 ➝ $170.00BuyView details for Guggenheim rating of Kymera Therapeutics (NASDAQ:KYMR) on 8/31/2026
Elastic N.V. stock logo
ESTC
Elastic
$83.61
+0.2%
8/28/2026Boost Price Target$106.00 ➝ $120.00BuyView details for Guggenheim rating of Elastic (NYSE:ESTC) on 8/28/2026
Autodesk, Inc. stock logo
ADSK
Autodesk
$212.59
+0.5%
8/28/2026Boost Price Target$277.00 ➝ $283.00BuyView details for Guggenheim rating of Autodesk (NASDAQ:ADSK) on 8/28/2026
Best Buy Co., Inc. stock logo
BBY
Best Buy
$91.19
+3.5%
8/28/2026Boost Price Target$90.00 ➝ $95.00BuyView details for Guggenheim rating of Best Buy (NYSE:BBY) on 8/28/2026
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$203.91
+0.3%
8/28/2026Boost Price Target$240.00 ➝ $275.00BuyView details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 8/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
$248.30
+2.2%
8/27/2026Reiterated Rating$228.00BuyView details for Guggenheim rating of Salesforce (NYSE:CRM) on 8/27/2026
Okta, Inc. stock logo
OKTA
Okta
$166.43
-2.7%
8/27/2026Set Price Target$162.00 ➝ $188.00BuyView details for Guggenheim rating of Okta (NASDAQ:OKTA) on 8/27/2026
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$32.11
+0.1%
8/27/2026Boost Price Target$55.00 ➝ $57.00BuyView details for Guggenheim rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 8/27/2026
CrowdStrike stock logo
CRWD
CrowdStrike
$205.90
-1.4%
8/27/2026Reiterated RatingNeutralView details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 8/27/2026
Guidewire Software, Inc. stock logo
GWRE
Guidewire Software
$141.09
+0.7%
8/27/2026Boost Price Target$180.00 ➝ $210.00BuyView details for Guggenheim rating of Guidewire Software (NYSE:GWRE) on 8/27/2026
Everpure, Inc. stock logo
P
Everpure
$97.43
+3.5%
8/27/2026Reiterated Rating$150.00BuyView details for Guggenheim rating of Everpure (NYSE:P) on 8/27/2026
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$262.71
+0.7%
8/27/2026Boost Price Target$276.00 ➝ $310.00BuyView details for Guggenheim rating of Veeva Systems (NYSE:VEEV) on 8/27/2026
Williams-Sonoma, Inc. stock logo
WSM
Williams-Sonoma
$225.89
+1.0%
8/27/2026Reiterated RatingNeutralView details for Guggenheim rating of Williams-Sonoma (NYSE:WSM) on 8/27/2026
DICK'S Sporting Goods, Inc. stock logo
DKS
DICK'S Sporting Goods
$134.98
+1.4%
8/26/2026 Reiterated RatingNeutralView details for Guggenheim rating of DICK’S Sporting Goods (NYSE:DKS) on 8/26/2026
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
$17.57
+3.3%
8/26/2026Reiterated RatingBuyView details for Guggenheim rating of Summit Therapeutics (NASDAQ:SMMT) on 8/26/2026
Fox Corporation stock logo
FOX
FOX
$58.44
+0.6%
8/25/2026 Reiterated RatingBuyView details for Guggenheim rating of FOX (NASDAQ:FOX) on 8/25/2026
Dollar Tree, Inc. stock logo
DLTR
Dollar Tree
$117.23
-1.2%
8/25/2026Boost Price Target$135.00 ➝ $145.00BuyView details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 8/25/2026
Fox Corporation stock logo
FOXA
FOX
$65.87
+1.1%
8/25/2026Reiterated Rating$85.00BuyView details for Guggenheim rating of FOX (NASDAQ:FOXA) on 8/25/2026
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$14.15
-1.2%
8/25/2026Reiterated Rating$28.00BuyView details for Guggenheim rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 8/25/2026
Snowflake Inc. stock logo
SNOW
Snowflake
$324.84
-1.5%
8/24/2026 Reiterated RatingNeutralView details for Guggenheim rating of Snowflake (NYSE:SNOW) on 8/24/2026
Reformation Inc. stock logo
REF
Reformation
$13.96
+6.2%
8/24/2026Initiated Coverage$20.00BuyView details for Guggenheim rating of Reformation (NYSE:REF) on 8/24/2026
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$128.08
+1.0%
8/24/2026Reiterated RatingBuyView details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 8/24/2026
Rubrik, Inc. stock logo
RBRK
Rubrik
$86.16
-3.1%
8/24/2026Boost Price Target$110.00 ➝ $116.00BuyView details for Guggenheim rating of Rubrik (NYSE:RBRK) on 8/24/2026
Eloxx Pharmaceuticals, Inc. stock logo
ELOX
Eloxx Pharmaceuticals
$15.80
-2.9%
8/24/2026Reiterated Rating$43.00BuyView details for Guggenheim rating of Eloxx Pharmaceuticals (NASDAQ:ELOX) on 8/24/2026
Jersey Mike's stock logo
JMKE
Jersey Mike's
$21.80
-0.3%
8/24/2026Initiated Coverage$28.00BuyView details for Guggenheim rating of Jersey Mike’s (NYSE:JMKE) on 8/24/2026
Reformation Inc. stock logo
REF
Reformation
$13.96
+6.2%
8/24/2026Initiated Coverage$20.00BuyView details for Guggenheim rating of Reformation (NYSE:REF) on 8/24/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$163.87
+0.2%
8/24/2026Reiterated Rating$214.00BuyView details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 8/24/2026
Workday, Inc. stock logo
WDAY
Workday
$185.78
+0.4%
8/21/2026 Reiterated Rating$275.00BuyView details for Guggenheim rating of Workday (NASDAQ:WDAY) on 8/21/2026
Advance Auto Parts, Inc. stock logo
AAP
Advance Auto Parts
$45.02
+4.0%
8/21/2026 Reiterated RatingNeutralView details for Guggenheim rating of Advance Auto Parts (NYSE:AAP) on 8/21/2026
Lowe's Companies, Inc. stock logo
LOW
Lowe's Companies
$197.01
+0.2%
8/21/2026Lower Price Target$300.00 ➝ $275.00BuyView details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 8/21/2026
Walmart Inc. stock logo
WMT
Walmart
$107.12
+1.3%
8/21/2026Set Price Target$135.00 ➝ $130.00BuyView details for Guggenheim rating of Walmart (NASDAQ:WMT) on 8/21/2026
CrowdStrike stock logo
CRWD
CrowdStrike
$205.90
-1.4%
8/20/2026 Reiterated RatingNeutralView details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 8/20/2026
Okta, Inc. stock logo
OKTA
Okta
$166.43
-2.7%
8/20/2026Boost Price Target$138.00 ➝ $162.00BuyView details for Guggenheim rating of Okta (NASDAQ:OKTA) on 8/20/2026
Target Corporation stock logo
TGT
Target
$155.52
-0.1%
8/20/2026Boost Price Target$150.00 ➝ $175.00BuyView details for Guggenheim rating of Target (NYSE:TGT) on 8/20/2026
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$262.71
+0.7%
8/20/2026Boost Price Target$232.00 ➝ $276.00BuyView details for Guggenheim rating of Veeva Systems (NYSE:VEEV) on 8/20/2026
Freenome stock logo
FRNM
Freenome
$14.55
-1.6%
8/20/2026Initiated Coverage$21.00BuyView details for Guggenheim rating of Freenome (NASDAQ:FRNM) on 8/20/2026
Autodesk, Inc. stock logo
ADSK
Autodesk
$212.59
+0.5%
8/20/2026Boost Price Target$245.00 ➝ $277.00BuyView details for Guggenheim rating of Autodesk (NASDAQ:ADSK) on 8/20/2026
SentinelOne, Inc. stock logo
S
SentinelOne
$19.76
-0.3%
8/20/2026Boost Price Target$24.00 ➝ $28.00BuyView details for Guggenheim rating of SentinelOne (NYSE:S) on 8/20/2026
CalciMedica Inc. stock logo
CALC
CalciMedica
$2.06
-3.0%
8/20/2026Initiated CoverageBuyView details for Guggenheim rating of CalciMedica (NASDAQ:CALC) on 8/20/2026
Salesforce Inc. stock logo
CRM
Salesforce
$248.30
+2.2%
8/20/2026Reiterated Rating$228.00BuyView details for Guggenheim rating of Salesforce (NYSE:CRM) on 8/20/2026
Freenome stock logo
FRNM
Freenome
$14.55
-1.6%
8/20/2026Initiated Coverage$21.00BuyView details for Guggenheim rating of Freenome (NASDAQ:FRNM) on 8/20/2026
GitLab Inc. stock logo
GTLB
GitLab
$46.92
-0.8%
8/19/2026Reiterated RatingNeutralView details for Guggenheim rating of GitLab (NASDAQ:GTLB) on 8/19/2026
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$32.11
+0.1%
8/19/2026Boost Price Target$40.00 ➝ $55.00BuyView details for Guggenheim rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 8/19/2026
Elastic N.V. stock logo
ESTC
Elastic
$83.61
+0.2%
8/19/2026Reiterated Rating$106.00BuyView details for Guggenheim rating of Elastic (NYSE:ESTC) on 8/19/2026
The Home Depot, Inc. stock logo
HD
Home Depot
$309.02
+1.1%
8/19/2026Reiterated Rating$425.00BuyView details for Guggenheim rating of Home Depot (NYSE:HD) on 8/19/2026
Scribe Therapeutics Inc. stock logo
SCTX
Scribe Therapeutics
$30.50
+3.5%
8/18/2026Initiated Coverage$50.00BuyView details for Guggenheim rating of Scribe Therapeutics (NASDAQ:SCTX) on 8/18/2026
MongoDB, Inc. stock logo
MDB
MongoDB
$362.53
-3.0%
8/18/2026Boost Price Target$475.00 ➝ $560.00BuyView details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 8/18/2026
LGN stock logo
LGN
LGN
$56.62
+5.7%
8/18/2026Reiterated Rating$115.00BuyView details for Guggenheim rating of LGN (NASDAQ:LGN) on 8/18/2026
Scribe Therapeutics Inc. stock logo
SCTX
Scribe Therapeutics
$30.50
+3.5%
8/18/2026Initiated Coverage$50.00BuyView details for Guggenheim rating of Scribe Therapeutics (NASDAQ:SCTX) on 8/18/2026
Celcuity, Inc. stock logo
CELC
Celcuity
$83.96
-1.8%
8/17/2026Boost Price Target$165.00 ➝ $175.00BuyView details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 8/17/2026
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
$54.24
-0.2%
8/17/2026Reiterated Rating$123.00 ➝ $104.00BuyView details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 8/17/2026
Walmart Inc. stock logo
WMT
Walmart
$107.12
+1.3%
8/17/2026Reiterated Rating$137.00 ➝ $135.00BuyView details for Guggenheim rating of Walmart (NASDAQ:WMT) on 8/17/2026
Yesway, Inc. stock logo
YSWY
Yesway
$22.71
+2.6%
8/17/2026Boost Price Target$30.00 ➝ $32.00BuyView details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 8/17/2026
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
$1.08
-3.2%
8/17/2026Lower Price Target$5.00BuyView details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 8/17/2026
Liberty Media Corporation - Liberty Formula One Series C stock logo
FWONK
Liberty Media Corporation - Liberty Formula One Series C
$95.74
+0.3%
8/17/2026Boost Price Target$125.00 ➝ $134.00BuyView details for Guggenheim rating of Liberty Media Corporation - Liberty Formula One Series C (NASDAQ:FWONK) on 8/17/2026
Liberty Media Corporation - Liberty Formula One Series A stock logo
FWONA
Liberty Media Corporation - Liberty Formula One Series A
$87.23
+0.3%
8/14/2026Boost Price Target$116.00 ➝ $124.00BuyView details for Guggenheim rating of Liberty Media Corporation - Liberty Formula One Series A (NASDAQ:FWONA) on 8/14/2026
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
$31.02
+1.1%
8/14/2026Reiterated Rating$60.00BuyView details for Guggenheim rating of Birkenstock (NYSE:BIRK) on 8/14/2026
Globant S.A. stock logo
GLOB
Globant
$37.58
+2.4%
8/14/2026Lower Price Target$55.00 ➝ $50.00BuyView details for Guggenheim rating of Globant (NYSE:GLOB) on 8/14/2026
The Madison Square Garden Company stock logo
MSGS
Madison Square Garden
$388.51
-0.9%
8/14/2026Boost Price Target$522.00 ➝ $584.00BuyView details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 8/14/2026
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$31.46
+1.1%
8/14/2026Reiterated Rating$55.00BuyView details for Guggenheim rating of Zenas BioPharma (NASDAQ:ZBIO) on 8/14/2026
Pharvaris N.V. stock logo
PHVS
Pharvaris
$38.45
+2.5%
8/13/2026Boost Price Target$39.00 ➝ $40.00BuyView details for Guggenheim rating of Pharvaris (NASDAQ:PHVS) on 8/13/2026
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
Unicycive Therapeutics, Inc. stock logo
UNCY
Unicycive Therapeutics
$5.32
+0.1%
8/13/2026Reiterated Rating$37.00 ➝ $25.00BuyView details for Guggenheim rating of Unicycive Therapeutics (NASDAQ:UNCY) on 8/13/2026
Erasca, Inc. stock logo
ERAS
Erasca
$16.15
+0.7%
8/13/2026Boost Price Target$20.00 ➝ $21.00BuyView details for Guggenheim rating of Erasca (NASDAQ:ERAS) on 8/13/2026
Everpure, Inc. stock logo
P
Everpure
$97.43
+3.5%
8/13/2026Boost Price Target$115.00 ➝ $150.00BuyView details for Guggenheim rating of Everpure (NYSE:P) on 8/13/2026
SCYNEXIS, Inc. stock logo
SCYX
SCYNEXIS
$4.86
+3.3%
8/13/2026Reiterated Rating$24.00 ➝ $33.00BuyView details for Guggenheim rating of SCYNEXIS (NASDAQ:SCYX) on 8/13/2026
CAVA Group, Inc. stock logo
CAVA
CAVA Group
$55.82
+3.4%
8/13/2026Lower Price Target$100.00 ➝ $95.00BuyView details for Guggenheim rating of CAVA Group (NYSE:CAVA) on 8/13/2026
STUB stock logo
STUB
STUB
$6.05
+1.6%
8/13/2026Lower Price Target$12.50 ➝ $11.00BuyView details for Guggenheim rating of STUB (NYSE:STUB) on 8/13/2026
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
$28.80
+0.3%
8/13/2026Reiterated Rating$45.00BuyView details for Guggenheim rating of ArriVent BioPharma (NASDAQ:AVBP) on 8/13/2026
Madison Square Garden Entertainment Corp. stock logo
MSGE
Madison Square Garden Entertainment
$77.94
+2.9%
8/12/2026Boost Price Target$82.00 ➝ $103.00BuyView details for Guggenheim rating of Madison Square Garden Entertainment (NYSE:MSGE) on 8/12/2026
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$33.31
-2.3%
8/12/2026Boost Price Target$45.00 ➝ $52.00BuyView details for Guggenheim rating of Cogent Biosciences (NASDAQ:COGT) on 8/12/2026
Neurogene Inc. stock logo
NGNE
Neurogene
$36.08
-0.1%
8/12/2026Boost Price Target$69.00 ➝ $81.00BuyView details for Guggenheim rating of Neurogene (NASDAQ:NGNE) on 8/12/2026

MarketBeat's community ratings are surveys of what our community members think about Guggenheim and other research firms in the last 90 days. Vote "Outperform" if you believe Guggenheim's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Guggenheim's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

Guggenheim's equity research team has issued ratings on 379 companies across 11 sectors over the past 12 months, covered by 31 analysts. The Guggenheim analysts below are listed by number of ratings issued in the last year.

Guggenheim Stock Coverage by Sector

Guggenheim concentrates its research most heavily in Healthcare (47.4%), Consumer Discretionary (18.1%) and Technology (13.0%). The chart below shows how Guggenheim's 386 rated companies are distributed across all 11 sectors it covers.

Guggenheim - Frequently Asked Questions

Guggenheim's analysts currently have buy-equivalent ratings on 326 companies. Recent upgrades to buy include Quanta Services, Autodesk, AppFolio, Guidewire Software and Freshworks.

Guggenheim's highest-rated analysts by MarketBeat's accuracy score include Seamus Fernandez, Subbu Nambi and Yatin Suneja. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 36 analysts at Guggenheim.

Guggenheim has the deepest coverage in Healthcare (47.4% of rated companies), Consumer Discretionary (18.1% of rated companies), Technology (13.0% of rated companies), Communication Services (8.8% of rated companies) and Industrials (5.7% of rated companies).

Guggenheim issued 1,131 ratings over the last 12 months across 386 companies — an average of roughly 94 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Guggenheim analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Guggenheim uses Buy, Neutral, and Sell as their equivalents.